Denali Therapeutics outlines 2026 milestones including Hunter syndrome launch

Go back to Denali Therapeutics outlines 2026 milestones including Hunter syndrome launch
(NASDAQ: DNLI) Delayed: 22.65 -0.61 (2.62%)
Previous Close $23.26    52 Week High
Open $23.33    52 Week Low
Day High $23.86    P/E N/A 
Day Low $22.53    EPS
Volume 966,692